Small-Molecule Induction Promotes Corneal Endothelial Cell Differentiation From Human iPS Cells

Area of Science:

• Stem cell biology
• Ophthalmology
• Regenerative medicine

Background:

• Corneal endothelial cells (CECs) are vital for corneal transparency and function.
• Loss of CECs leads to blindness, necessitating cell replacement therapies.
• Current cell replacement strategies rely on donated or differentiated CECs.

Purpose of the Study:

• To develop an efficient protocol for differentiating human induced pluripotent stem cells (hiPSCs) into CECs using small molecules.
• To identify specific small molecules that promote this differentiation process.
• To investigate the underlying molecular mechanisms involved in CEC differentiation.

Main Methods:

• hiPSCs were differentiated into neural crest cells (NCCs) using dual-SMAD inhibition.
• A small-molecule library screen was performed to induce NCCs into CECs.
• Cell characteristics were analyzed using real-time PCR, immunofluorescence, and Western blotting.

Main Results:

• An effective small molecule-based protocol was established to generate hiPSC-derived CECs (hiPSC-CECs).
• Key CEC markers (ZO-1, AQP1, Vimentin, Na+/K+-ATPase) were confirmed in hiPSC-CECs.
• A combination of A769662 and AT13148 demonstrated the highest efficiency in CEC production.
• This combination upregulated the PKA/AKT pathway, FOXO1, and PITX2, facilitating NCC to CEC conversion.

Conclusions:

• An efficient small molecule-driven method for differentiating hiPSCs into corneal endothelial-like cells has been established.
• This method holds potential for advancing drug discovery in corneal diseases.
• The findings support the development of novel cell-based therapies for corneal blindness.